The Hospital Clínic-IDIBAPS leads the largest European study to date on liver disease
The project, funded by the European Union and endowed with a budget of 24.8 million euros, aims to identify a large set of biomarkers that allow li...
The project, funded by the European Union and endowed with a budget of 24.8 million euros, aims to identify a large set of biomarkers that allow li...
Researchers at the Hospital Clínic-IDIBAPS led an international study, published in the journal The Lancet, in which they designed an index to dete...
The consortium has begun the second clinical trial to evaluate the efficiency of the combined treatment of simvastatin and the antibiotic rifaximin...
This analysis, the largest conducted to date and led by Hospital Clínic–IDIBAPS researchers, provides evidence of the inefficacy of this therapeuti...
A study carried out entirely at the Hospital Clínic - IDIBAPS has determined that mitochondrial function in the metabolism of white blood cells is...
A study conducted by researchers from the Hospital Clínic-IDIBAPS and the CIBEREHD that has been published by the Journal of Hepatology shows that...
Professionals from the Hospital Clínic-IDIBAPS and CIBEREHD participated in the preparation of the international guidelines produced by the America...
A study led by researchers from the Clínic-IDIBAPS and the CIBEREHD and published in the Journal of Hepatology shows that up to 9% of patients with...
A study coordinated by researchers of the Clínic-IDIBAPS and published in The Lancet Gastroenterology & Hepatology establishes the safe dose of sim...